Clearmind Medicine Inc. Common Shares (CMND)
Clearmind Medicine Inc. is a biotechnology company focused on developing psychedelic-based treatments for mental health disorders. The company aims to leverage novel compounds and research to address conditions such as addiction, depression, and other psychiatric issues. Based in Canada, Clearmind collaborates with scientific and clinical partners to advance its innovative therapies.
Company News
The substance use disorder market is expected to grow between 2025 and 2034, driven by greater awareness, the introduction of new therapies, and ongoing research and development efforts. The report covers the market assessment of Alcohol Use Disorder, Cocaine Use Disorder, Opioid Use Disorder, and Cannabis Use Disorder.
Shares of Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose sharply in today’s pre-market trading after the company reported a year-over-year increase in FY23 EPS results. The company reported fiscal year 2023 losses of 96 cents per share, compared to losses of $3.78 per share from the prior year. Taysha reported it had $143.9 million in cash an...
Top 10 Penny Stocks To Watch Under $1 This Week. The post 10 Top Penny Stocks To Watch Right Now For Under $1 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.